Patient, tumor, and treatment characteristics at the time of breast cancer diagnosis in BRCA1 versus BRCA2 carriers according to the timing of germline BRCA testing are reported in the Data Supplement (Table S1, online only). The gene discussed is BRCA2; the disease is breast carcinoma.